Alvotech‘s biosimilar facility was opened in June 2016. The mandate was to create a unique concept for an efficient, flexible, green, biosimilar facility, capable of delivering predefined quantities of biosimilar products, produced by the highest quality standards. The facility is flexible and allows operation to adapt to market demands with minimal changeover time.
The facility is operating with single use bioreactor technology. We purify, formulate and fill our products in house, for supply of finished and ready to commercialize products to our partners worldwide. Our laboratories are equipped with the latest technologies to allow the testing and release of our products with the best precision available.
Alvotech’s focus isn’t solely on the health and wellbeing of patients around the globe, but also on the health of our planet.
This is another reason for locating our headquarters, manufacturing and operations in Iceland where almost 100 percent of the total energy supply is derived from domestically produced renewable energy, namely geothermal energy and hydro-electric power.
Green energy is therefore one of the pillars of Alvotech’s Corporate Social Responsibility policy.